Among them, the basal triple negative breast cancer (TNBC) does not express estrogen and progesterone receptors (ER−, PR−), nor overexpresses HER2, and usually has an inactive p53 mutant [10,11,12]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.